Insider · CIK 0002144116
John Spencer
Files at OGEN (ORAGENICS INC). First filing -, latest -.
In brief
John Spencer files SEC Form 4 as CFO at OGEN (ORAGENICS INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; John Spencer has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | OGEN ORAGENICS INC | AGrant or award Employee Stock Option (right to buy)derivative | +55,900 | $0.00 | $0 | 55,900 | Jul 7, 2026 |
Questions about John Spencer
Answered from the filings on this page, as of the latest one.
Is John Spencer buying or selling?
John Spencer has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did John Spencer's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John Spencer has 0.
Where does John Spencer file Form 4?
John Spencer has filed Form 4 at OGEN (ORAGENICS INC) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.